Schedule 13D ownership disclosure

TCR2 THERAPEUTICS INC

Security class unavailable · CUSIP: 87808K106

Event date: 2019-02-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-062378
Form type
SC 13D
Filer
MPM BioVentures 2014, L.P.
CIK
CIK 1609492
Filed
Mar 04, 2019
Reporting period
Feb 19, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub